LM
Luminus Management LLC
13F filer · CIK 0001279151Reported Aug 14, 2026
Net seller this quarter
13F portfolio value$146MU.S. long equity reported on 13F
Positions3013 new · 7 closed
Net flow last quarter-$15.2MBuys minus sells
Top 10 positions weight88.7%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 14, 202630 positions | |||||
| $24.7M | 16.86% | 0.73% | +58.9% | Q2 2021 | |
| $17.1M | 11.69% | 1.16% | -34.8% | Q4 2022 | |
| $16.1M | 11.03% | 0.52% | -16.4% | Q1 2016 | |
| $14.5M | 9.92% | 0.30% | New | Q2 2026 | |
| $13.3M | 9.12% | 0.23% | +305.3% | Q2 2025 | |
| $12.4M | 8.49% | 0.45% | -42.6% | Q1 2025 | |
| $9.83M | 6.72% | 0.28% | -0.2% | Q2 2013 | |
| $9.18M | 6.28% | 0.29% | -46.1% | Q4 2018 | |
| $8.67M | 5.92% | 0.06% | Not reported | Q4 2025 | |
| $3.91M | 2.67% | 0.08% | Not reported | Q2 2013 | |
| $3.1M | 2.12% | 0.10% | New | Q2 2026 | |
| $2.51M | 1.72% | 0.01% | New | Q2 2026 | |
| $1.71M | 1.17% | Not reported | +181.8% | Q4 2020 | |
| $1.61M | 1.10% | 0.22% | -6.0% | Q4 2019 | |
| $1.4M | 0.96% | 2.75% | -46.7% | Q1 2020 | |
| $1.3M | 0.89% | 0.01% | Not reported | Q4 2018 | |
| $1.26M | 0.86% | 0.04% | New | Q2 2026 | |
| $553K | 0.38% | 0.00% | -86.5% | Q2 2013 | |
| $473K | 0.32% | 0.10% | New | Q2 2026 | |
| $458K | 0.31% | 0.15% | New | Q2 2026 | |
| $448K | 0.31% | 0.01% | New | Q2 2026 | |
| $292K | 0.20% | 0.28% | Not reported | Q1 2020 | |
| $288K | 0.20% | Not reported | -55.0% | Q1 2026 | |
| $247K | 0.17% | 0.04% | New | Q2 2026 | |
| $215K | 0.15% | 1.19% | Not reported | Q1 2025 | |
| $212K | 0.14% | 1.30% | +215.4% | Q1 2026 | |
| $142K | 0.10% | 0.00% | Not reported | Q4 2025 | |
| $118K | 0.08% | 1.32% | Not reported | Q1 2026 | |
| $91.1K | 0.06% | 0.98% | +1.8% | Q4 2025 | |
| $74.5K | 0.05% | 0.06% | -94.7% | Q3 2025 | |
| Q1 2026Reported May 15, 202624 positions | |||||
| $28.6M | 17.29% | 1.78% | +73.1% | Q4 2022 | |
| $20.7M | 12.52% | 0.63% | +162.7% | Q1 2016 | |
| $18M | 10.90% | 0.54% | Not reported | Q4 2018 | |
| $16.9M | 10.22% | 0.78% | +75.7% | Q1 2025 | |
| $15.2M | 9.21% | 0.46% | +112.3% | Q2 2021 | |
| $12.7M | 7.68% | 0.28% | Not reported | Q2 2013 | |
| SASEESealed Air Corp | $12.3M | 7.41% | 0.20% | -18.8% | Q2 2016 |
| $11.1M | 6.68% | 0.19% | +101.1% | Q4 2014 | |
| $7.83M | 4.73% | 9.77% | -67.4% | Q1 2020 | |
| $7.45M | 4.50% | 0.06% | -0.3% | Q4 2025 | |
| $3.61M | 2.18% | 0.02% | Not reported | Q2 2013 | |
| $3.37M | 2.03% | 0.06% | -40.0% | Q2 2025 | |
| $1.77M | 1.07% | 0.23% | Not reported | Q4 2019 | |
| $1.03M | 0.63% | 0.00% | New | Q1 2026 | |
| $982K | 0.59% | Not reported | -50.0% | Q4 2020 | |
| $808K | 0.49% | 1.07% | +386.3% | Q3 2025 | |
| $663K | 0.40% | Not reported | New | Q1 2026 | |
| $560K | 0.34% | 0.10% | New | Q1 2026 | |
| $522K | 0.32% | 0.13% | New | Q1 2026 | |
| STSGMOQSangamo Therapeutics, Inc | $415K | 0.25% | 0.41% | +45.1% | Q3 2025 |
| $266K | 0.16% | 0.22% | New | Q1 2026 | |
| $226K | 0.14% | 1.00% | +13.2% | Q4 2025 | |
| $225K | 0.14% | 1.41% | New | Q1 2026 | |
| $201K | 0.12% | 12.55% | New | Q1 2026 | |
| Q4 2025Reported Feb 17, 202621 positions | |||||
| $23.2M | 20.33% | 1.02% | -23.1% | Q4 2022 | |
| $18.4M | 16.12% | Not reported | Not reported | Q1 2025 | |
| SASEESealed Air Corp | $14.9M | 13.02% | 0.24% | -28.1% | Q2 2016 |
| $10.6M | 9.32% | 0.45% | +28.2% | Q1 2025 | |
| $6.95M | 6.09% | 37.38% | Not reported | Q1 2020 | |
| $6.42M | 5.62% | 0.09% | Not reported | Q4 2014 | |
| $6.18M | 5.41% | 0.22% | +326.1% | Q2 2021 | |
| $5.69M | 4.99% | 0.09% | +87.3% | Q2 2025 | |
| $4.77M | 4.17% | 0.06% | New | Q4 2025 | |
| $4.22M | 3.70% | 0.24% | -79.7% | Q1 2016 | |
| $2.6M | 2.28% | 0.03% | Not reported | Q2 2013 | |
| $1.46M | 1.27% | Not reported | +31.0% | Q4 2020 | |
| $501K | 0.44% | 0.62% | Not reported | Q2 2025 | |
| STSGMOQSangamo Therapeutics, Inc | $487K | 0.43% | 0.33% | +363.5% | Q3 2025 |
| $408K | 0.36% | 0.59% | New | Q4 2025 | |
| $404K | 0.35% | 0.28% | -59.4% | Q4 2021 | |
| $367K | 0.32% | 0.22% | +5.1% | Q3 2025 | |
| $320K | 0.28% | 0.01% | New | Q4 2025 | |
| $232K | 0.20% | 0.89% | New | Q4 2025 | |
| $165K | 0.14% | 0.05% | New | Q4 2025 | |
| $79.3K | 0.07% | Not reported | New | Q4 2025 | |
| Q3 2025Reported Oct 3, 202519 positions | |||||
| $28M | 25.13% | 1.18% | -14.4% | Q1 2016 | |
| $26.5M | 23.84% | 1.33% | +15.1% | Q4 2022 | |
| SASEESealed Air Corp | $17.6M | 15.86% | 0.34% | +15.1% | Q2 2016 |
| $9.76M | 8.77% | 0.21% | +292.0% | Q1 2020 | |
| $7.97M | 7.16% | 0.35% | -41.3% | Q1 2025 | |
| $7.44M | 6.69% | 37.38% | Not reported | Q1 2020 | |
| $3.05M | 2.75% | 0.05% | -46.4% | Q2 2025 | |
| $2.17M | 1.95% | 0.07% | Not reported | Q4 2018 | |
| SOSOCSable Offshore Corp. | $1.75M | 1.57% | 0.10% | +3.1% | Q2 2025 |
| $1.53M | 1.37% | 0.05% | Not reported | Q2 2021 | |
| $1.39M | 1.25% | Not reported | +76.8% | Q4 2020 | |
| $1.13M | 1.01% | 0.01% | Not reported | Q2 2014 | |
| $922K | 0.83% | 0.66% | +14.8% | Q4 2021 | |
| $432K | 0.39% | 0.22% | -46.3% | Q1 2024 | |
| MTMRSNMersana Therapeutics, Inc. | $388K | 0.35% | 1.00% | -95.2% | Q2 2025 |
| $356K | 0.32% | 0.21% | New | Q3 2025 | |
| $346K | 0.31% | 0.06% | New | Q3 2025 | |
| $326K | 0.29% | 1.17% | -4.7% | Q1 2025 | |
| STSGMOQSangamo Therapeutics, Inc | $168K | 0.15% | 0.08% | New | Q3 2025 |
Premium opens every quarter this fund has filed